Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$2.89 USD
-0.12 (-3.99%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $2.90 +0.01 (0.35%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Kodiak Sciences Inc. [KOD]
Reports for Purchase
Showing records 121 - 127 ( 127 total )
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Our Presenting Companies at the ROTH Conference and 2020 Catalyst Calendar
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Our Presenting Companies at the ROTH Conference and 2020 Catalyst Calendar
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
KSI-301 Shows Increasing Durability While Maintaining Competitive Efficacy
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and $115 PT
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z